This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter       

Cardiovascular

18
Research into increasing fitness for major surgery
Research into increasing fitness for major surgery
Read more
Treatment of heart attack patients depends on history of cancer
Treatment of heart attack patients depends on history of cancer
Read more
Vessel preparation for DCB with atherectomy
Read more
Cardiovascular disease in patients living with HIV
Read more
Cardiac manifestations of Fabry disease
Read more
Neprilysin/angiotensin inhibition in heart failure
Read more
Proximal endovascular occlusion for CAS
Read more
Golden Jubilee National Hospital goes live with Patient Portal
Golden Jubilee National Hospital goes live with Patient Portal
Read more
New FIT diabetes injection ‘Golden Rules’
New FIT diabetes injection ‘Golden Rules’
Read more
Hodgkin lymphoma survivors have more severe coronary artery disease post-chest irradiation
Hodgkin lymphoma survivors have more severe coronary artery disease post-chest irradiation
Read more
AF patients say ‘yes’ to the freedom that self-monitoring gives them
AF patients say ‘yes’ to the freedom that self-monitoring gives them
Read more
Hospital introduces Phillips Minicare cTnI point of care blood test for suspected heart attack patients
Hospital introduces Phillips Minicare cTnI point of care blood test for suspected heart attack patients
Read more
Heart rhythm charity raises alarm at variable quality of care for patients at risk of sudden cardiac arrest
Heart rhythm charity raises alarm at variable quality of care for patients at risk of sudden cardiac arrest
Read more
SMC accepts six new medicines for routine use in NHS Scotland
SMC accepts six new medicines for routine use in NHS Scotland
Read more
NovoRapid® receives positive CHMP opinion for extended use in children as young as one year old
NovoRapid® receives positive CHMP opinion for extended use in children as young as one year old
Read more
Victoza® lowers progression of kidney damage in diabetic adults at high CV risk
Victoza® lowers progression of kidney damage in diabetic adults at high CV risk
Read more
Saving lives and cutting costs in atrial fibrillation
Saving lives and cutting costs in atrial fibrillation
Read more
Informed, inspired care
Informed, inspired care
Read more

Popular articles

Redefining management of uveal melanoma liver metastases: what oncologists need to know
Diagnostic AI tool ‘more accurate’ than physicians aims to ‘reshape’ healthcare
Be alert to Guillain-Barré risk after RSV vaccination in older adults, says MHRA
Forgo radioiodine ablation after thyroidectomy in low-risk cancer patients, say researchers
P2Y12 inhibitor monotherapy has lower MACCE risk than aspirin after PCI, study finds



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x